Business
CardioComm Solutions Awarded Canadian Space Agency Contract for Design of Next Generation Connected Care Medical Module Prototype
GEMS(TM) C2M2 will Detect, Diagnose, Treat and Monitor Health Conditions for Use in Space Mission...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions Awarded Canadian Space Agency Contract for Design of Next Generation Connected Care Medical Module PrototypeGEMS(TM) C2M2 will Detect, Diagnose, Treat and Monitor Health Conditions for Use in Space Missions and in Remote Communities on Earth.Toronto, Ontario--(Newsfile Corp. - October 16, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm\" or the \"Company\"), a global medical provider and pioneer of Remote Patient Monitoring (RPM) solutions for direct-to-consumer heart monitoring and prescribed ambulatory electrocardiogram (\"ECG\") software and hardware solutions, is pleased to announce it has been awarded, through a competitive process, up to $150,000 in funding from the Canadian Space Agency (CSA) for design of the next generation prototype for the CSA's Connected Care Medical Module (C2M2)1.The CSA C2M2 is a highly innovative, AI-supported system designed to address the unique challenges of medical care in isolated environments, whether in space or on Earth. This dual use, both in space and for terrestrial applications, makes the C2M2 a critical development for improving healthcare accessibility and reliability in environments where traditional medical care is hard to access. The CardioComm prototype, GEMS™ C2M2, will build on CardioComm's experience in the development of innovative and device-agnostic RPM software platforms for cardiac medical monitoring. The Company recently expanded its cardiac RPM technologies through its innovative Body-by-GEMS™ program, which provides for a device-agnostic solution for monitoring of multiple bio-signals including ECG, temperature, SpO2, blood pressure and heart rate. The CSA C2M2 funding will facilitate the Company's expansion into a broader range of near real-time RPM of multiple bio-signals including development of protocols for autonomous differential diagnosis, treatment and follow-up monitoring of patients where limited access to medical services exists.The key components CardioComm will develop in their design (GEMS™ C2M2) are:Artificial Intelligence (AI) Supported Computer System:Facilitates incorporation and interconnection of medical technologies: GEMS™ C2M2 will be device-agnostic and will integrate a wide array of medical devices and technologies, ensuring seamless communication between them, through standardized p...